Early occurrence of red blood cell alloimmunization in patients with sickle cell disease

Autor: Sins, J.W.R., Biemond, B.J., Bersselaar, S.M. van den, Heijboer, H., Rijneveld, A.W., Cnossen, M.H., Kerkhoffs, J.L.H., Meurs, A.H. van, Ronnen, F.B. von, Zalpuri, S., Rijke, Y.B. de, Schoot, C.E. van der, Haas, M. de, Bom, J.G. van der, Fijnvandraat, K.

Publikováno v: American Journal of Hematology, 91(8), 763-769. Wiley-Liss Inc.
American journal of hematology, 91(8), 763-769. Wiley-Liss Inc.
American Journal of Hematology, 91(8), 763-769

Red blood cell (RBC) alloimmunization is a major complication of transfusion therapy in sickle cell disease (SCD). Identification of high-risk patients is hampered by lack of studies that take the cumulative transfusion exposure into account. In this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::097b428a85fb912363247d99b4bc8634
https://pure.eur.nl/en/publications/43eaf0aa-8dd4-490f-9a0d-94f9a84fc2b0